At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5,540 enrolled
Drug / intervention
Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patientsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Absence of Standard Modifiable Risk Factors Among 5000 Middle Eastern Patients With Atherosclerotic Cardiovascular Disease: Clinical Profiles and Prevalence of Other Risk Factors and Comorbidities
In Brief
An observational study evaluating Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patients for Cardiovascular Risk Factors. Completed, enrolled 5,540 participants across 2 sites.
Detailed Summary
A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Risk Factors
CountriesJordan
Timeline
N/ACompletedFinished
202420252026
First PostedJan 2024
Enrollment StartJan 2024
Primary CompletionJan 2025
Study CompletionJan 2025
TodayJul 2026
First PostedJan 10, 2024
Enrollment StartJan 22, 2024
Primary CompletionJan 1, 2025
Study CompletionJan 31, 2025
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 2.5 years ago
Interventions
Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patientsother
Individuals identified with a diagnosis of ASCVD will fill a one page form of the associated risk factors they have